Rainbow Childrens Medicare

Rainbow Childrens Medicare

1,525.10
-15.70
(-1.02%)
Market Cap
15,647.10 Cr
EPS
23.97
PE Ratio
60.63
Dividend Yield
0.20 %
52 Week High
1,709.60
52 Week Low
1,129.00
PB Ratio
10.63
Debt to Equity
0.56
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from7 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
positive
Rainbow Children's Medicare has reaffirmed its revenue growth guidance of 18-20% for FY26, expecting demand to strengthen in upcoming quarters. The company posted a strong EBITDA margin of 29.4% in Q1 FY26 but will not revise its full-year guidance upward. Chairman and Managing Director Dr. Ramesh Kancharla indicated that margins may face pressure as three new hospitals with approximately 250 beds become operational this year. The company expects pre-Ind AS margins of 24-25% and post-Ind AS margins of 29-30% for FY26. Average revenue per patient is projected to grow 6% year-on-year, consistent with earlier projections. The rise in average revenue per occupied bed has been driven by stronger case mix including pediatric surgical, specialty, and quaternary care services like cardiac transplants and neurosurgeries. Surgical revenues demonstrated strong momentum with at least 15% growth in both volume and value. However, overall hospital occupancy declined to around 40% due to seasonal slowdown in outpatient and pediatric intensive care segments.
positive
Rainbow Children's Medicare Limited announced its unaudited financial results for the quarter ended June 30, 2025. On a standalone basis, the company reported revenue from operations of Rs. 3,347.48 million and profit after tax of Rs. 517.20 million, with basic earnings per share of Rs. 5.09. On a consolidated basis, revenue from operations stood at Rs. 3,529.29 million with profit after tax of Rs. 538.05 million and basic earnings per share of Rs. 5.27. The board designated Dr. Pranathi Subrahmanyam Maddirala, Clinical Director of Obstetrics and Fetal Medicine, as Senior Management Personnel. The company also granted 140,810 stock options under ESOP 2025 to eligible employees and completed the acquisition of 76% equity stake in Prashanthi Medicare Private Limited for Rs. 326 million. A final dividend of Rs. 3 per equity share for FY 2024-25 was paid on July 5, 2025.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,274.30
#1 1,22,237.70
108.01
7,184.10
18.77
1,076
26.84
56.58
7,456.00
1,05,775.20
73.16
#1 21,794.00
14.74
1,513
60.41
57.81
850.60
63,888.30
75.79
7,849.70
8.99
809
-7.43
70.84
1,982.60
40,694.40
51.05
5,482.98
10.96
807
3.41
52.00
1,331.40
36,404.30
70.04
3,692.32
#1 25.09
486
-20.35
63.43
749.85
30,852.70
81.93
3,035.10
12.94
409
48.39
58.64
591.50
29,861.90
80.45
4,138.46
22.85
#1 5,417
#1 3,986.36
50.04
1,525.10
#8 15,647.10
#3 60.63
#9 1,566.90
#5 17.46
#8 244
#4 35.52
50.67
1,439.20
9,431.00
#1 49.93
1,290.20
17.77
194
-0.88
38.22
586.95
7,893.70
177.70
2,218.14
12.97
28
-71.06
61.87

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
17.46 %
Net Income Growth
11.86 %
Cash Flow Change
23.11 %
ROE
-4.06 %
ROCE
3.26 %
EBITDA Margin (Avg.)
-1.17 %

Quarterly Financial Results

Quarterly Financials
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
166
249
271
255
219
243
321
315
326
295
341
345
354
342
429
411
385
373
Expenses
132
168
177
160
164
155
204
200
219
200
215
218
236
237
270
264
255
249
EBITDA
34
80
94
95
54
88
117
115
107
96
125
127
118
106
158
148
129
124
Operating Profit %
20 %
32 %
34 %
36 %
23 %
35 %
35 %
35 %
31 %
31 %
35 %
35 %
31 %
28 %
35 %
34 %
31 %
29 %
Depreciation
20
19
21
21
22
22
23
23
23
25
27
28
32
34
35
35
34
34
Interest
13
13
12
12
16
14
13
14
14
15
13
14
17
18
18
18
18
18
Profit Before Tax
2
48
61
62
16
52
81
78
70
56
85
85
69
53
105
94
77
71
Tax
1
12
16
17
4
13
20
20
16
14
22
22
18
14
26
25
20
18
Net Profit
1
36
45
45
12
39
62
58
54
42
63
63
51
40
79
69
57
54
EPS in ₹
0.14
3.91
4.87
4.79
1.36
3.78
6.06
5.74
5.31
4.04
6.20
6.12
5.02
3.89
7.77
6.76
5.55
5.27

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
231
349
399
448
926
1,019
1,081
1,296
1,771
2,170
2,377
Fixed Assets
78
123
174
296
702
702
772
858
931
1,253
1,398
Current Assets
98
171
125
73
133
203
197
290
478
622
822
Capital Work in Progress
35
31
7
12
23
43
29
6
23
20
29
Investments
7
2
6
0
3
10
18
22
58
308
571
Other Assets
111
194
212
140
199
265
262
409
759
590
380
Total Liabilities
231
349
399
448
926
1,019
1,081
1,296
1,771
2,170
2,377
Current Liabilities
36
42
56
71
92
130
122
125
139
150
151
Non Current Liabilities
15
13
14
15
463
480
511
564
567
756
751
Total Equity
181
295
329
362
372
409
448
606
1,065
1,265
1,475
Reserve & Surplus
166
275
309
307
317
351
392
498
958
1,157
1,367
Share Capital
15
20
20
55
55
55
55
105
102
102
102

Cash Flow

Cash Flow
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
-1
3
1
-2
2
2
-1
4
7
-7
10
Investing Activities
-113
-20
-107
-33
-42
-117
-117
-83
-175
-465
-227
-268
Operating Activities
15
26
17
36
48
127
170
143
224
329
321
396
Financing Activities
98
-7
93
-1
-8
-9
-52
-61
-44
143
-102
-118

Share Holding

% Holding
Dec 2021
May 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
63.70 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.88 %
49.85 %
49.85 %
49.85 %
49.85 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
21.63 %
22.32 %
24.04 %
24.78 %
25.11 %
25.12 %
23.69 %
23.59 %
DIIs
0.00 %
6.35 %
6.55 %
10.26 %
13.90 %
15.38 %
15.35 %
15.40 %
15.62 %
14.76 %
13.80 %
13.83 %
13.87 %
15.31 %
15.44 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
19.03 %
15.87 %
13.24 %
13.75 %
13.29 %
13.04 %
11.92 %
11.03 %
10.40 %
10.74 %
10.40 %
10.38 %
10.34 %
10.32 %
Others
36.30 %
24.79 %
27.75 %
26.67 %
22.52 %
21.50 %
21.78 %
1.22 %
1.21 %
0.97 %
0.80 %
0.80 %
0.77 %
0.79 %
0.79 %
No of Share Holders
146
2,43,189
1,66,064
91,530
79,224
75,611
74,690
79,187
80,471
77,152
78,557
77,524
78,764
79,092
80,320

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 2 3 3 3
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.28 0.23 0.21 0.19

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
26 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 Jul 2025 1,526.50 1,554.50
05 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
05 Jul 2025 1,352.30 1,599.40
28 Jun 2025 DIVIDEND Dividend
₹ 3.00 /share
27 Jun 2025 1,352.30 1,512.95
24 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 May 2025 1,366.75 1,352.30
09 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Feb 2025 1,423.75 1,383.95
27 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Oct 2024 1,431.30 1,417.75
30 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Jul 2024 1,393.75 1,172.30
23 Jul 2024 DIVIDEND Dividend
₹ 3.00 /share
23 Jul 2024 1,393.75 1,145.75
22 Jun 2023 DIVIDEND Dividend
₹ 3.00 /share
22 Jun 2023 849.65 977.25
08 Sept 2022 DIVIDEND Dividend
₹ 2.00 /share
07 Sept 2022 489.05 611.60

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome1 day ago
Announcement under Regulation 30 (LODR)-Newspaper Publication1 day ago
Announcement under Regulation 30 (LODR)-Investor Presentation3 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release3 days ago
Grant Of Stock Options3 days ago
Announcement under Regulation 30 (LODR)-Change in Management3 days ago
Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On July 26 20253 days ago
Unaudited Financial Results For The Quarter Ended June 30 20253 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation7 days ago
Board Meeting Intimation for Approval Of Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter Ended June 30 2025.8 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 07, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 05, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJul 01, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJun 28, 2025
Closure of Trading WindowJun 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 14, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 13, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jun 13, 2025
Reg. 34 (1) Annual Report.Jun 13, 2025
Notice Of 27Th Annual General Meeting To Be Held On July 5 2025Jun 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 09, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 03, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 31, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 26, 2025
Appointment Of Secretarial Auditor Internal Auditors & Cost Auditors Of The CompanyMay 24, 2025
The Record Date For Payment Of The Final Dividend Has Been Fixed As June 28 2025May 24, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 24, 2025
Corporate Action-Board approves DividendMay 24, 2025
Convening Of 27Th AGM Of The Company On July 5 2025May 24, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 24, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 24, 2025
Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On May 24 2025May 24, 2025
Audited Financial Results For The Quarter And Financial Year Ended March 31 2025May 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 17, 2025
Board Meeting Intimation for Approval Of Audited (Standalone & Consolidated) Financial Results For The Period Ended March 31 2025 And To Consider Recommending Final Dividend If Any.May 17, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 13, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 03, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 06, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 04, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 03, 2025
Update On Purchase Of Land Parcels Located In Sector 44 & Sector 56 Of Gurugram Haryana.Mar 01, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 15, 2025

Technical Indicators

RSI(14)
Neutral
50.67
ATR(14)
Less Volatile
49.06
STOCH(9,6)
Neutral
39.46
STOCH RSI(14)
Oversold
16.02
MACD(12,26)
Bearish
-4.47
ADX(14)
Strong Trend
32.54
UO(9)
Bearish
43.78
ROC(12)
Downtrend And Accelerating
-0.65
WillR(14)
Oversold
-82.77

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
HSBC Focused Fund Direct - Growth
0.89%
-52200
-0.37%
-0.42%
ICICI Prudential Midcap Direct Plan-Growth
0.11%
50000
0.11%
0.11%
Kotak Healthcare Fund Direct - Growth
1.61%
46600
1.61%
1.61%
ICICI Prudential Retirement Fund - Pure Equity Plan Direct - Growth
0.38%
31837
0.38%
0.38%
UTI Healthcare Fund Direct-Growth
1.17%
24432
0.41%
0.40%
UTI Multi Cap Fund Direct-Growth
1.42%
23965
0.21%
1.42%
Motilal Oswal Small Cap Fund Direct - Growth
2.53%
20000
0.18%
-0.11%
Motilal Oswal Active Momentum Fund Direct - Growth
2.95%
19825
2.95%
2.95%
Bandhan Aggressive Hybrid Fund Direct-Growth
0.28%
17679
0.28%
0.28%
Edelweiss Multi Cap Fund Direct - Growth
0.08%
15600
0.08%
0.08%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
0.28%
11280
0.28%
0.28%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
0.93%
10588
0.46%
-0.32%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.39%
1558
0.02%
-0.01%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.21%
1140
0.04%
0.03%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.38%
671
0.01%
-0.02%
SBI Nifty Smallcap 250 Index Fund Direct - Growth
0.39%
311
0.02%
-0.01%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
0.38%
270
0.02%
-0.01%
Tata Nifty MidSmall Healthcare Index Fund Direct - Growth
1.32%
231
0.06%
0.06%
WhiteOak Capital Equity Savings Fund Direct - Growth
0.08%
203
0.02%
0.00%
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
0.10%
-96
0.00%
0.00%
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0.38%
95
0.01%
-0.02%
Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth
1.31%
-65
0.06%
0.05%
Kotak Nifty Smallcap 250 Index Fund Direct-Growth
0.39%
53
0.02%
-0.01%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.38%
49
0.01%
-0.01%
Motilal Oswal Nifty 500 Index Fund Direct - Growth
0.04%
47
0.00%
0.00%

About Rainbow Childrens Medicare

Rainbow Children's Medicare Limited is a leading chain of multi-specialty pediatric, obstetrics, and gynecology hospitals in India. Originally incorporated in 1998, it operates 16 hospitals and three clinics across six cities, with a total bed capacity of 1,655. The company specializes in pediatric services, including newborn and pediatric intensive care, multi-specialty services, and quaternary care, as well as obstetrics and gynecology services. Founded by Dr. Ramesh Kancharla, Rainbow follows a full-time, exclusive doctor-led model of healthcare delivery. The company expanded its services over the years, establishing hospitals in various cities and introducing new specialties. In 2022, Rainbow completed an Initial Public Offering and its shares were listed on the National Stock Exchange of India Limited and BSE Limited. The company also offers post-graduate DNB and fellowship programs in pediatrics.
Listing Date
10 May, 2022(3 Years, 20 days)
Chairperson NameRamesh Kancharla